Search Results 381-390 of 2998 for ✏[광고텔레:TOOPPC] 구글상단도배대행 휴게텔광고 출장광고 백링크광고 카지노솔루션 찌라시배포✏
The trial is designed to demonstrate non-inferiority of Adherus Dural Sealant to DuraSeal Exact. Subjects who have consented to participate in this study prior ...
This exploratory study will also serve as a signal seeking endeavor to demonstrate biologic effect associated with TD-1473 through biomarker analysis and ...
The purpose of this study is to test the feasibility, compliance, and impact of synchronous physician engagement for patients (adult and pediatric) being cared ...
The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.
This is a multicenter, open-label, first-time-in-human study with a standard 3+3 dose-escalation phase in subjects with advanced solid tumors followed by an ...
The purpose of this study is to determine the side effects of treatment with Nivolumab by itself or in combination in patients with relapsed/refractory ...
About this study. This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, phase 2 study in ...
About this study. Skeletal muscle abnormalities (sarcopenia) and frailty are common complications seen in patients with end-stage liver disease.
ODC components include: the NeuroCatch™ Platform [quantified electroencephalogram (qEEG)] developed by NeuroCatch Inc., the King-Devick Test (in association ...
View research collaborators of Mayo Clinic's Neuroregeneration and Neurorehabilitation Lab, led by Isobel A. Scarisbrick, Ph.D.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.